Please visit booth #837 for free samples!
About us:
Calmoseptine Inc. markets Calmoseptine Ointment in all 50 states in the United States, Canada, Australia, Philippines, United Arab Emirates, and Jordan. Calmoseptine Inc. has focused its marketing efforts toward hospitals, skilled nursing facilities and home health care agencies.
The road to market or the distribution network of Calmoseptine Inc. in all countries, is through the leading wholesalers and/or distributors respectively. In the US and Canada key partners are McKesson, AmerisourceBergen, Cardinal Health, and Medline while in Asia Pacific we work with Zuellig Pharma. As for trade partners, Calmoseptine Inc. sells Calmoseptine Ointment through the largest retail pharmacies in the US such as CVS, Walgreens, and Walmart while the Philippines has established patient and consumer access through strong partnerships with Mercury Drug and Rose Pharmacy.
Based on the success in the US and the Philippines, Calmoseptine Inc. intends to widen the global footprint further in into Asia and also to Europe. The focus in 2019 is on ASEAN with Indonesia, Vietnam and Thailand as key targets while in 2020, pre-launch work will commence in the European Union.
Calmoseptine Ointment is Calmoseptine Inc.’s sole product. This has allowed the company to be more innovative & flexible with its road to market models whilst always adhering to strict regulatory and ethical compliance guidelines. Health care professionals recommend Calmoseptine Ointment because of its unique properties not offered by its competitors. The benefits of Calmoseptine Ointment is reflected by its popularity with wound nurses (WOCNs - wound ostomy and continence nurses) which observe the patient benefits on a daily basis. These nurses are decision makers to purchase ointments like Calmoseptine Ointment for private and public hospitals throughout the world.
More about the product:
Calmoseptine Ointment is an effective, multi-purpose moisture barrier that protects and helps heal skin irritations. People who benefit from Calmoseptine Ointment are those needing protection or those with impaired skin integrity related to urinary and fecal incontinence, feeding tube site leakage, fecal or vaginal fistula drainage, insect bites, moisture/perspiration, diaper dermatitis, and minor scrapes and burns. It also temporarily relieves discomfort and itching.
Calmoseptine Ointment is available in 2.5-ounce jars or tubes, 4-ounce tubes, one-eighth- ounce packets, and 20g tubes through most United States wholesalers, distributors and pharmacies. Calmoseptine Ointment is currently selling over 8.5 million (3.5 gram) foil packets in the Philippines.
For Indonesia, Calmoseptine Inc. is proposing to follow the success of the Philippines and solely focus on the 3.5 gram foil packets. Competitive pricing combined with a smart and sustainable marketing/sales approach aims to mirror the successes in the US and the Philippines.
Greg Dixon, the founder and owner of Calmoseptine Inc. for 30 years, is also the founder and owner of Calmo Manufacturing Inc., a high tech pharmaceutical company that was designed to solely produce Calmoseptine Ointment. Calmo Manufacturing Inc's facilities were completed and licensed by the USA FDA in 2010 and complies with Current Good Manufacturing Practices and Good Laboratory Practices. Both, the manufacturing plant and the office are located in Huntington Beach, California.
Brands: Calmoseptine Ointment